Key facts
- This page summarizes Nola E. Masterson's Form 4 filing for Zivo Bioscience, Inc. (ZIVO).
- 7 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 06 Jun 2024, 18:28.
Nola E. Masterson - 05 Jun 2024 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)
- Reporting relationship
- Director
- Issuer ticker
- ZIVO
- Reported as of
- 05 Jun 2024
- Net transaction value
- +$676,130
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2024, 18:28:46 UTC
- Prior SEC filing
- 14 Jun 2023
- Next SEC filing
- 13 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nola E. Masterson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nola E. Masterson filed Form 4 for Zivo Bioscience, Inc. (ZIVO) on 06 Jun 2024.
Change
- Previous filing in this sequence was filed on 14 Jun 2023.
- Current net transaction value: +$676,130.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZIVO
transaction
Common Stock
Award
- Transaction value
- Shares
- +30,010
- Change %
- +3465%
- Price
- Shares after
- 30,876
- Date
- 05 Jun 2024
- Ownership
- Direct
- Footnotes
- F3
ZIVO
transaction
Common Stock
Award
- Transaction value
- $676,130
- Shares
- +84,941
- Change %
- +275%
- Price
- $7.96
- Shares after
- 115,817
- Date
- 05 Jun 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -1,902
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,902
- Exercise price
- $26.88
- Footnotes
- F1, F2, F3
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,333
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,333
- Exercise price
- $33.00
- Footnotes
- F1, F2, F3
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -2,632
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,632
- Exercise price
- $21.66
- Footnotes
- F1, F2, F3
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -707
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 707
- Exercise price
- $17.16
- Footnotes
- F1, F2, F3
ZIVO
transaction
Derivative
Nonstatutory Stock Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -3,626
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,626
- Exercise price
- $16.74
- Footnotes
- F1, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
Footnote F2
The canceled options were fully vested.
Footnote F3
The Issuer canceled options for an aggregate 13,200 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 30,010 shares of restricted stock.
Footnote F4
The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.